Current studies have demonstrated that NCAPG was involved in the pathogenesis of a variety of malignant tumors, such as hepatocellular carcinoma, renal cell carcinoma, breast cancer, and prostate cancer [24–27]. The gene discussed is NCAPG; the disease is renal cell carcinoma.